BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
03.07.25
/
50%
€48.80
Target price
03.07.26
€82.17
Performance (%)
9.02%
Price
24.02.26
€53.20
Summary
This prediction is currently active. With a performance of 9.02%, the BUY prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 03.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.138% | 5.138% |
| iShares Core DAX® | 0.024% | 0.583% |
| iShares Nasdaq 100 | 1.740% | -2.061% |
| iShares Nikkei 225® | 0.428% | 10.487% |
| iShares S&P 500 | 1.329% | 0.140% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $97.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€84.06
28.10.26
28.10.26
13.43%
24.02.26
24.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.36
22.07.25
22.07.25
€82.12
22.07.26
22.07.26
5.64%
24.02.26
24.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
-26.63%
27.04.25
27.04.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24